Cleaved capase 9 immunoreactivity has been reported in viral vector-based models of synucleinopathy [44], [45], so we evaluated activation of caspase 9 in end-stage hA30Pα-syn mice (Figure 8B). This evidence concerns the gene CASP9 and synucleinopathy.